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Background In children, psoriasis can be challenging to diagnose. Difficulties arise
from differences in the clinical presentation compared with adults.
Objectives To test the diagnostic accuracy of previously agreed consensus criteria
and to develop a shortlist of the best predictive diagnostic criteria for childhood
psoriasis.
Methods A case–control diagnostic accuracy study in 12 UK dermatology depart-
ments (2017–2019) assessed 18 clinical criteria using blinded trained investiga-
tors. Children (< 18 years) with dermatologist-diagnosed psoriasis (cases, N=
170) or a different scaly inflammatory rash (controls, N = 160) were recruited.
The best predictive criteria were identified using backward logistic regression,
and internal validation was conducted using bootstrapping.
Results The sensitivity of the consensus-agreed criteria and consensus scoring algo-
rithm was 846%, the specificity was 651% and the area under the curve (AUC)
was 075. The seven diagnostic criteria that performed best were: (i) scale and
erythema in the scalp involving the hairline, (ii) scaly erythema inside the exter-
nal auditory meatus, (iii) persistent well-demarcated erythematous rash anywhere
on the body, (iv) persistent erythema in the umbilicus, (v) scaly erythematous
plaques on the extensor surfaces of the elbows and/or knees, (vi) well-
demarcated erythematous rash in the napkin area involving the crural fold and
(vii) family history of psoriasis. The sensitivity of the best predictive model was
768%, with specificity 727% and AUC 084. The c-statistic optimism-adjusted
shrinkage factor was 0012.
Conclusions This study provides examination- and history-based data on the clinical
features of psoriasis in children and proposes seven diagnostic criteria with good
discriminatory ability in secondary-care patients. External validation is now needed.
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What is already known about this topic?
• A diagnosis of psoriasis may be delayed in children and young people, and psoria-
sis may be misdiagnosed in primary and secondary care.
• Diagnostic criteria for psoriasis in adults and children have been lacking.
• The development of criteria will aid recognition and clinical diagnosis of psoriasis,
and provide a disease definition for clinical trials and epidemiological studies.
• Studies to develop diagnostic criteria should aim to minimize bias in the study
design.
What does this study add?
• The consensus-agreed 16 diagnostic criteria and proposed scoring system demon-
strated good diagnostic accuracy.
• Using statistical modelling, a shortlist of the seven best predictive diagnostic cri-
teria was identified. The presence of two or more of these criteria had a sensitivity
and specificity of over 70%.
• The criteria provide a reminder to clinicians that psoriasis in children can often
develop in skin covered by hair and clothing.
Psoriasis is a chronic immune-mediated inflammatory skin dis-
ease affecting the skin and joints. The World Health Organiza-
tion (WHO) has identified psoriasis as a serious
noncommunicable disease and an area of unmet health need.1
Ensuring prompt diagnosis and identifying other priority areas
for research are highlighted by both the WHO and the Psoria-
sis Priority Setting Partnership.2,3
Making the diagnosis of psoriasis in children and young
people can be more challenging than in adults. The presenta-
tion of psoriasis in children is often more subtle, with thin-
ner, less hyperkeratotic plaques. The distribution often
involves the flexures, face and skin covered by clothing and
hair, which can be easily missed if these areas are not specifi-
cally asked about and examined.4,5 Psoriasis in children is also
under-recognized in primary and secondary care. Reasons for
this may include a lack of awareness that psoriasis can develop
from infancy onwards, and psoriasis being misdiagnosed as
other common childhood rashes such as atopic dermatitis/
eczema, skin infections and exanthems.6,7 The evidence to
guide treatment and monitoring in childhood psoriasis is lim-
ited. For many children psoriasis can persist into adulthood
and there is the potential for a cumulative negative effect over
many years.8–11
Currently, diagnosis is based on the recognition of clinical
signs and symptoms. There are no diagnostic criteria in rou-
tine use in clinical practice or research.12 The lack of a stan-
dardized disease definition and case ascertainment impacts on
the validity and generalizability of the evidence, and is a limi-
tation of many existing studies.13–16 Also, timely recognition
of psoriasis is important for referral to a specialist, access to
effective treatment and identification of juvenile psoriatic
arthritis.8
To address this an eDelphi consensus study was completed
with the International Psoriasis Council to agree a list of
criteria important for the diagnosis of psoriasis in children
and to propose a scoring algorithm for diagnosis.17 The aim
of this study (DIPSOC) was to test the diagnostic accuracy of
the consensus-agreed criteria and to refine the criteria using
multivariate analysis. Through refinement the aim was to
identify a shortlist of the best predictive criteria.
Patients and methods
Protocol, ethics and study registration
The DIPSOC study protocol has been published as an open-
access manuscript.18 A summary of the protocol contents is
provided below, highlighting any changes made as post hoc
decisions. Health Regulatory Authority and National Health
Service Research Ethics Committee (REC) approvals were
granted in February 2017 (REC reference 17/EM/0035). The
study was registered on the ISRCTN website in November
2017 (https://doi.org/10.1186/ISRCTN98851260).
Study design and setting
DIPSOC was a multicentre diagnostic accuracy case–control
study that recruited in 12 UK paediatric dermatology depart-
ments. A nested substudy following a cohort of children with
possible or indeterminate psoriasis is ongoing. The study fol-
lows the STARD and TRIPOD reporting guidelines.19,20
Objectives
The primary objective of the DIPSOC study was to test the
diagnostic accuracy of the consensus-agreed criteria for plaque
psoriasis in children and young people and to develop a short-
list of the best predictive diagnostic criteria using multivariate
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analysis. The secondary objectives were: (i) to compare the
diagnostic performance of the consensus-agreed diagnostic cri-
teria and the best predictive criteria for plaque psoriasis in
children and young people, (ii) to assess the interobserver var-
iability in the diagnostic criteria assessment and (iii) to assess
the variability in the reference standard for psoriasis.
Participant selection
Inclusion criteria were children and young people aged 0–18
years with active skin disease (rash present) at the time of
assessment and a dermatologist’s diagnosis made in a paediatric
dermatology clinic of either (i) psoriasis (cases) or (ii) a scaly
inflammatory rash other than psoriasis (controls). Children and
young people with possible or indeterminate psoriasis, or pus-
tular or erythrodermic psoriasis, or without a dermatologist’s
confirmed diagnosis of their skin disease were excluded.
Study recruitment and assessment
Consecutive new and follow-up patients were identified in
clinic or from existing medical records. Potential participants
who met the eligibility criteria were approached by their usual
dermatology team and recruited. The index test was divided
into two parts: (i) the 16 consensus-agreed diagnostic criteria
and scoring algorithm (one major and/or three minor criteria)
identified through an eDelphi consensus study with the Inter-
national Psoriasis Council (Table 1), and (ii) the best predictive
criteria developed in this study from 18 criteria (16 consensus
criteria plus two criteria close to reaching consensus) using
multivariate analysis. The reference standard was a dermatolo-
gist’s diagnosis, deemed clinically appropriate. The index test
and reference standard data were obtained on the same day.
At the research visit, data on demographics, quality of life
[Children’s Dermatology Life Quality Index (CDLQI) and
Child Health Utility 9D] and the presence or absence of each
of the 18 diagnostic criteria on history and examination were
collected. The investigator performing the assessment of diag-
nostic criteria had completed standardized training and was
blinded to the participant’s diagnosis. To evaluate interobser-
ver variability in assessment of the diagnostic criteria, the
assessment was conducted consecutively by two independent
assessors in the first 40 participants where two assessors were
available. Data on the reference standard, disease history and
severity were extracted from the medical record.
Sample size
The full statistical analysis plan was finalized before the end of
recruitment and is available at: www.nottingham.ac.uk/go/
dipsoc. Two calculations were made based on the two parts of
the primary objective. The highest value was from the TRI-
POD rule of thumb of 10 observations for each predictor vari-
able. For 16 consensus-agreed criteria, a sample size of 160
cases and 160 controls was required (320 participants in
total).
Data analysis
Stata version v16.0 was used to undertake the analysis (Stata-
Corp, College Station, TX, USA). The participant characteristics
of the study population were described using descriptive sta-
tistics; continuous variables that were normally distributed are
presented as mean (SD) and categorical variables as number
and percentage. The diagnostic accuracy of the consensus-
agreed criteria, based on the suggested scoring algorithm, was
calculated as sensitivity, specificity, area under the curve
(AUC) and likelihood ratio.
Predictive model
The frequency, sensitivity, specificity, univariate odds ratio
and likelihood ratios of the individual 18 diagnostic cri-
teria were calculated. Diagnostic criteria that did not reach
80% sensitivity and 80% specificity were included as pre-
dictors (minor criteria); this was an a priori decision.
Diagnostic criteria with fewer than 10 observations were
excluded because infrequently seen clinical signs would
not be helpful in the majority of children; this was a post
hoc decision.
The predictive model used backward logistic regression and
the criteria in the final model were defined as the ‘best predic-
tive criteria’. The linear predictor using coefficients in the
model was used to estimate the probability of psoriasis. The
Table 1 Consensus-agreed diagnostic criteria from an eDelphi study
with the International Psoriasis Council.17 Two additional diagnostic
features (*) have also been included that were close to reaching
consensus and were emphasized as important in the feedback from
experts
Major criteria
Scaly erythematous plaques on the extensor surfaces of the
elbows and knees
Scaly erythematous plaques on the trunk triggered by a sore
throat or other infection
Raindrop plaques typical of guttate disease on the trunk or limbs
Minor criteria
Scale and erythema in the scalp involving the hairline
Retroauricular erythema (including behind the earlobes)
Scaly erythema inside the external auditory meatus
Persistent well-demarcated erythematous scaly rash anywhere on
the body
Fine scaly patches involving the upper thighs and buttocks
Well-demarcated erythematous rash in the napkin area involving
the crural folds
Persistent erythema in the umbilicus
Nail pitting
Onycholysis of the nail(s)
Subungual hyperkeratosis of the nail(s)
Positive family history of psoriasis
Koebner phenomenon
Fusiform swelling of a toe or a finger suggestive of dactylitis
*Persistent well-demarcated facial rash with fine or absent scale
*Natal cleft erythema and/or skin splitting
© 2021 The Authors. British Journal of Dermatology
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sensitivity, specificity, AUC and likelihood ratios of the predic-
tive model were calculated.
Multicollinearity, calibration and discrimination were assessed
using cross-tabulation, the Hosmer–Lemeshow statistic and
receiver operator characteristic (ROC) curves, respectively.
The ROC curves for the consensus-agreed diagnostic criteria
and the best predictive diagnostic criteria were compared visu-
ally. The interobserver variability in the assessment of the indi-
vidual diagnostic criteria was estimated using the Kappa statistic.
Stratification
Stratification was used to assess the diagnostic ability of the
criteria in different subgroups: age (< 10 years or ≥ 10 years),
sex and dermatological experience of the assessor. Other
planned stratification analyses were not possible due to insuffi-
cient data in the strata leading to unstable estimates.
Internal validation
The bootstrap procedure was conducted for internal valida-
tion; this was repeated 1000 times to obtain a distribution of
optimism estimates and the average optimism was calcu-
lated.21 The bootstrap-corrected c-statistic, calibration in the
large and calibration slope were computed by subtracting the
optimism from the original values.
Missing data
The proportions of missing data for each variable are pre-
sented as numbers and percentages. A complete-case analysis
(all diagnostic criteria observations recorded) was used for the
predictive model, and the effect of coding missing observa-
tions as ‘yes’ or ‘no’ on the model was explored.
Exploration of different cutoffs
A post hoc decision was made to explore the diagnostic accu-
racy of setting different cutoffs of the positive best predictive
criteria – for example, three or more of the best predictive
criteria. This was to simulate how the criteria may be most
naturally used in clinical practice, where clinicians would be
interested in the diagnostic accuracy of a minimum number
of diagnostic criteria.
Protocol amendment
Variability in the reference standard was not investigated
because an insufficient number of clinical images of suitable
quality were available for data collection in the study.
Patient and public involvement
Patient and public involvement through a patient coinvestigator and
the Young Person’s Advisory Group for Research have been integral
to the study question, study design and conduct of the study.
Results
Study population
In total 330 children and young people (< 18 years of age)
were recruited between October 2017 and March 2019. Of
these, 170 had a dermatologist’s confirmed diagnosis of psoria-
sis (cases) and 160 had been diagnosed with a different inflam-
matory skin disease (controls). The participant characteristics
are presented in Tables 2 and 3. Cases were more often female
(600% vs. 419%), were older at the time of the research visit
(111 vs. 74 years) and onset of the rash (70 vs. 12 years),
and were more often of white ethnicity (800% vs. 594%).
Nearly all of the controls were diagnosed with atopic dermati-
tis/eczema (referred to as eczema from here onwards) (944%).
A small proportion of cases and controls had supporting histo-
logical diagnosis (< 3%). Where disease severity was documen-
ted, 129% of cases and 194% of controls had severe or very
severe disease. For cases, the median Psoriasis Area and Severity
Index was 49 (interquartile range 25–115). Mean CDLQI
scores were similar between cases and controls (80 vs. 98).
Approximately one-third of the cases and controls were new
consultations (347% vs. 300%) and around one-fifth were
receiving systemic treatment (141% vs. 244%) or phototherapy
(59% vs. 25%).
Objective 1: Diagnostic accuracy of consensus-agreed
criteria
The frequency, univariate odds ratio, sensitivity, specificity
and likelihood ratios of the individual diagnostic criteria are
presented in Table 4. There were 16 consensus-agreed criteria;
the proposed threshold to support a diagnosis of psoriasis was
one major and/or three or more minor criteria. The diagnos-
tic accuracy and discrimination results for the consensus-
agreed criteria were 829% sensitivity, 65% specificity, AUC
074 [95% confidence interval (CI) 069–079], 237 positive
likelihood ratio (+LR) and 026 negative likelihood ratio
(−LR) (n= 320). The diagnostic accuracy results were similar
for the complete-case analysis (n= 308): 846% sensitivity,
651% specificity, AUC 075 (95% CI 070–080), +LR 242
and −LR 024 (Figure 1).
Objective 1: Predictive model development and
diagnostic accuracy
In total 18 diagnostic criteria were evaluated (16 consensus
agreed plus two borderline consensus criteria). Two diagnostic
criteria (hyperkeratosis of the nails, fusiform swelling of a fin-
ger or toe) with fewer than 10 observations were excluded
from the predictive model. None of the three consensus-
agreed major criteria reached the a priori threshold definition
for major criteria. Therefore, all of the remaining 16 criteria
were available for model selection. Seven criteria were
retained in the logistic regression model and are referred to as
the ‘best predictive criteria’ (Table 5, Figure 2).
© 2021 The Authors. British Journal of Dermatology
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The diagnostic accuracy and discrimination results of the best
predictive criteria based on the highest proportion correctly
classified were sensitivity 768%, specificity 727% and AUC
084 (95% CI 079–088) (n= 308) (Figure 1). The Hosmer–
Lemeshow statistic indicated good calibration (P= 066).
Internal validation of the predictive model
The c-statistic in the original sample was 084 (95% CI 080–
085), in the bootstrapped sample it was 085 (95% CI 078–
091) and the average optimism of the c-statistic was 0012
(95% CI −006 to 007) (Table S1; see Supporting
Information).
Diagnostic accuracy of the predictive model stratified for
subgroups
Stratification to assess the diagnostic accuracy of the predictive
model was possible for age at assessment, sex, and dermato-
logical experience of the assessor, and shows reasonably com-
parable performance across the groups (Appendix S1; see
Table 2 Demographic characteristics of cases (psoriasis) and controls
(other inflammatory skin diseases) included in the DIPSOC study
Cases (n= 170) Controls (n= 160)
Age of participants (years)
Mean (SD); range 111 (36); 13–179 74 (50); 04–176
Age at diagnosis (years)
Mean (SD); range 92 (37); 114–177 47 (42); 0–171
Missing 4 (24) 10 (63)
Age at onset of skin rash or symptoms (years)
Mean (SD); range 70 (37); 0–17 12 (31); 0–14
Missing 7 (41) 25 (156)
Sex, n (%)
Male 67 (394) 92 (575)
Female 102 (600) 67 (419)
Other 1 (06) 1 (06)
Ethnicity, n (%)
White 136 (800) 95 (594)
Asian 21 (124) 33 (206)
Black, African,
Caribbean
2 (12) 8 (50)
Arabic 2 (12) 1 (06)
Other 2 (12) 6 (38)
Mixed white/Asian 1 (06) 2 (13)
Mixed white/black 5 (29) 11 (69)
Mixed other 0 (0) 2 (13)
Prefer not to say 1 (06) 2 (13)





16 (94) 23 (144)
II. Intermediate
occupations













57 (335) 50 (313)
Unemployed 5 (29) 5 (31)
Other 29 (171) 27 (169)
Missing 10 (59) 10 (63)
Numbers of missing data are given only where data were missing.
Table 3 Diagnostic and quality-of-life characteristics of cases






Psoriasis 170 (100) NA
Eczema NA 152 (950)
Ichthyosis NA 3 (19)
Lichen planus NA 2 (13)
Keratosis pilaris NA 1 (06)




Psoriatic arthritis, n (%) 3 (18) NA
Histological diagnosis, n (%) 4 (24) 4 (25)
Consultation type, n (%)
New 59 (347) 48 (300)
Follow-up 111 (653) 112 (700)
Disease severity, n (%)
Mild or very mild 33 (194) 30 (188)
Moderate 32 (188) 33 (206)
Severe or very severe 22 (129) 31 (194)
Not documented 83 (488) 66 (413)
PASI, median (IQR) 49 (25–115) NA
PASI missing 104 (612) NA
Quality of life
CDLQI score, mean (SD) 80 (62) 98 (58)
CHU9D utility score,
median (IQR)
089 (013) 086 (018)
Not completed < 4 years old 3 52
Missing 0 2
Current treatment, n (%)
Topical 158 (929) 150 (938)
Systemic 24 (141) 39 (244)
Phototherapy 10 (59) 4 (25)
Diagnostic criteria assessor, n (%)
Dermatology consultant 4 (24) 3 (19)
Paediatric consultant 3 (18) 5 (31)
Dermatology registrar/fellow 54 (318) 39 (244)
Dermatology trained nurse 32 (188) 35 (219)
Other doctors 6 (35) 11 (69)
Other nurse 55 (324) 47 (294)
Other investigator 16 (94) 20 (125)
CDLQI, Children’s Dermatology Life Quality Index; CHU9D,
Child Health Utility 9D; IQR, interquartile range; NA, not appli-
cable; PASI, Psoriasis Area and Severity Index.
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Supporting Information). The stratification showed the perfor-
mance to be comparable, suggesting the criteria are suitable to
be used across different populations.
Missing data
The percentage of missing data for the presence or
absence of the diagnostic criteria was < 7%. Criteria
involving the nails (covered by nail varnish) or napkin
area were more likely to be missing. The effect of miss-
ing data was explored and there was no substantial
change in the diagnostic accuracy of the predictive
model when all missing observations were coded as ‘yes’
(735% sensitivity, 744% specificity, AUC 083) or ‘no’
(724% sensitivity, 763% specificity, AUC 083) (n =
330).

















DC1. Scale and erythema in the
scalp involving the hairline
89 (524) 27 (169) 541 (312–94) 524 (447–601) 831 (764–886) 310 057
DC2. Retroauricular erythema 85 (500) 34 (213) 371 (223–616) 50 (424–578) 788 (716–848) 236 063
DC3. Scaly erythema inside the
external auditory meatus
77 (453) 19 (119); 1 61 (332–112) 453 (377–531) 881 (82–926) 381 062
DC4. Persistent well-demarcated
facial rash with fine or absent
scale
55 (324) 22 (138) 3 (17–529) 324 (254–399) 863 (799–912) 236 078
DC5. Persistent well-demarcated
erythematous scaly rash anywhere
on the body
119 (704); 1 39 (245); 1 732 (422–127) 704 (629–772) 755 (68–819) 287 039
DC6. Scaly erythematous plaques
on the trunk triggered by a sore
throat or other infection
19 (112) 4 (25); 1 403 (130–125) 94 (548–148) 975 (937–993) 376 093
DC7. Raindrop plaques typical of
guttate disease on the trunk or
limbs
50 (294) 12 (75) 510 (253–103) 294 (227–369) 925 (872–960) 392 076
DC8. Persistent erythema in the
umbilicus
37 (218) 4 (25) 109 (359–328) 218 (158–287) 975 (938–993) 872 080
DC9. Scaly erythematous plaques
on the extensor surfaces of the
elbows and/or knees
88 (518) 35 (219) 383 (231–636) 518 (44–595) 781 (709–843) 237 062
DC10. Nail pitting 26 (157); 4 15 (94); 1 178 (090–352) 157 (105–221) 906 (849–946) 167 093
DC11. Onycholysis 9 (54); 3 6 (38); 1 145 (050–419) 54 (25–998) 962 (919–986) 142 098
DC12. Subungual hyperkeratosis 7 (42); 3 1 (06); 1 69 (083–578) 42 (17–84) 994 (965–999) 7 096
DC13. Fusiform swelling of a toe
or finger
2 (12) 0; 1 – 12 (014–418) 100 (978–100) – 099
DC14. Fine scaly patches involving
the upper thighs and/or buttocks
74 (443); 3 34 (221); 6 281 (170–464) 443 (366–522) 779 (705–842) 200 072
DC15. Well-demarcated
erythematous rash in the napkin
area involving the crural folda
35 (207); 1 5 (32); 4 789 (289–215) 207 (149–276) 968 (927–989) 647 082
DC16. Natal cleft erythema and/or
skin splitting
18 (107); 1 7 (44); 2 257 (104–638) 107 (644–163) 956 (911–982) 243 093
DC17. Koebner phenomenon 9 (53) 2 (13); 9 436 (092–208) 53 (245–981) 987 (955–998) 408 096
DC18. Family history – first and
second degree
102 (600) 43 (269) 408 (249–669) 60 (522–674) 731 (656–798) 223 055
DC18a. Family history – first
degree
64 (377) 15 (94) 584 (304–112) 377 (303–454) 906 (85–947) 401 069
DC18b. Family history – second
degree
72 (424) 32 (200) 294 (177–489) 424 (347–502) 80 (730–859) 212 072
CI, confidence interval. aNapkin area is used to describe an area of skin in children and young people of all ages. It refers to the area that
would be covered by a nappy in younger children.
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Worked examples using the predictive criteria
The final equation for the prediction of psoriasis in children
(< 18 years) is as follows.
Probability of psoriasis ¼ expð1:717 þ 0:595 DC1
þ 0:644 DC3 þ 1:013 DC5 þ 1:173 DC8
þ 0:701 DC9 þ 1:05 DC15 þ 1:276 DC18Þ=
½1 þ expð1:717 þ 0:595 DC1 þ 0:644 DC3
þ 1:013 DC5 þ 1:173 DC8 þ 0:701 DC9 þ 1:05
 DC15 þ 1:276 DC18Þ:
A score of 1 is used if a criterion is present (positive) and a
score of 0 if a criterion is absent (negative). This equation can
be used to calculate the probability that a child has psoriasis.
Worked examples are provided in Appendix S1.
Diagnostic accuracy of the best predictive criteria
Table 6 provides data on the diagnostic accuracy of different
numbers of positive diagnostic criteria. These results suggest
that the presence of two or more diagnostic criteria can cor-
rectly identify 784% of children with psoriasis (sensitivity or
the true-positive rate), and 288% of children without psoria-
sis will be incorrectly identified as having psoriasis (1 −
specificity or the false-positive rate). These are the closest
values to the prespecified threshold of 80% sensitivity and
80% specificity.
Figure 1 Receiver operator characteristic (ROC) curves for (a) the consensus-agreed criteria and (b) the prediction model for the best predictive
criteria. Complete-case analysis, n= 308.
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Objective 2: Comparing the consensus-agreed criteria
and the best predictive criteria
The ROC curves for the two sets of criteria are presented in Figure 1.
Objective 2: Interobserver variability
The kappa statistics comparing assessment 1 and assessment 2
for each of the 18 diagnostic criteria for the first 40 partici-
pants recruited to the DIPSOC study are presented in Table S2
(see Supporting Information).
Discussion
The consensus-agreed diagnostic criteria achieved good diag-
nostic accuracy using the expert-agreed cutoff of one major or
at least three minor criteria. The consensus criteria were found
to have higher sensitivity than specificity, and the AUC
showed that discrimination between cases and controls was
moderate (AUC 074).22 Refinement of the criteria into a
shorter list of seven ‘best predictive’ criteria was achieved
using multivariate analysis (Figure 2): (i) scale and erythema
in the scalp involving the hairline, (ii) scaly erythema inside
the external auditory meatus, (iii) persistent well-demarcated
erythematous rash anywhere on the body, (iv) persistent
erythema in the umbilicus, (v) scaly erythematous plaques on
the extensor surfaces of the elbows and/or knees, (vi) well-
demarcated erythematous rash in the napkin area involving
the crural fold and (vii) family history of psoriasis. Three of
these criteria involve skin in hidden sites, which are often
covered by clothing or hair.
The diagnostic accuracy of the predictive model was also
good (sensitivity 768%, specificity 727%), with a slightly
higher AUC (084). The model nearly reached the desired
diagnostic accuracy of 80% sensitivity and 80% specificity.
After applying different cutoffs for the number of best predic-
tive criteria, two or more criteria is a proposed scoring cutoff,
which gives 784% sensitivity and 712% specificity. The cri-
teria performed sufficiently similarly in younger and older
children and when assessed by those with and without derma-
tology training. There was a difference in age at onset of
symptoms between children with and without psoriasis,
which would be interesting to explore as a criterion (predic-
tor) in future studies.
Validated clinical diagnostic criteria for different skin dis-
eases are very few in number. Most studies have developed
multiple sets of diagnostic criteria for two diseases: eczema
and Behçet disease.23,24 This is evidence that research to
develop diagnostic criteria has not been prioritized for skin
disease. This deficit is being addressed for psoriasis in adults
through research coordinated by the Global Psoriasis Atlas
(www.globalpsoriasisatlas.org). A consensus study with psori-
asis experts has identified nine criteria to support the diagnosis
of chronic plaque psoriasis in adults, focusing on the clinical
appearance of skin lesions.25 Diagnostic accuracy and valida-
tion studies for these criteria are now needed.
The DIPSOC study has been designed with careful adher-
ence to key quality components in diagnostic accuracy stud-
ies.19,26,27 Consecutive patients were approached and the
exclusion criteria kept to a minimum to minimize selection
bias. Bias related to the index test was minimized through
blinded assessments and prespecifying the diagnostic thresh-
old. The DIPSOC study recruited from 12 UK paediatric der-
matology departments, which provides clinical diversity of
patients and broader representation of a dermatologist’s diag-
nosis than a single-centre study. The study recruitment target
was successfully reached. The diagnostic accuracy of the
model was explored for different populations and clinical set-
tings, which are important for the clinical application of the
criteria. Investigators received standardized training but had a
range of dermatological experience; this better reflects the
broad final use of the diagnostic criteria.
An important limitation of the study is the choice of study
design and setting. A case–control design was chosen as a fea-
sible study design to test the diagnostic accuracy of the
consensus-agreed criteria and provide sufficient data for the
prediction model. The study design and recruitment from sec-
ondary care are likely to have introduced both selection and
spectrum bias, which lead to overestimation of the diagnostic
accuracy.26 However, the decision to include controls with
skin disease instead of healthy controls will have minimized
Table 5 Adjusted multivariate odds ratios (ORs) and coefficient values
of the seven best predictive diagnostic criteria in the prediction model




erythema in the scalp
involving the hairline



























266 (085–830) 0091 1050
DC18. Family history 366 (205–654) < 0001 1276
CI, confidence interval.
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this bias.28 Nearly all controls had a diagnosis of eczema, and
therefore the discriminatory ability of the criteria may be dif-
ferent when comparing against a more diverse group of con-
trols. Using a case–control design also fixes the prevalence,
therefore it is not possible to calculate the positive and nega-
tive predictive values. It was not possible to explore the vari-
ability in the reference standard as planned due to insufficient
clinical images of suitable quality. All participants were
required to have a dermatologist’s diagnosis made in a paedi-
atric dermatology clinic, but no data were collected on the
experience or paediatric dermatology training of the clinician.
The DIPSOC study was a development study and is the start-




Figure 2 Photographs showing the six clinical signs of the best predictive criteria for psoriasis in children and young people. One image per
criterion has been chosen and therefore will not be representative of all skin changes and skin tones in which psoriasis can be seen. (a) Scale and
erythema in the scalp involving the hairline. (b) Scaly erythema inside the external auditory meatus. (c) Persistent well-demarcated erythematous
scaly rash anywhere on the body. (d) Persistent erythema in the umbilicus. (e) Scaly erythematous plaques on the extensor surfaces of the elbows
and/or knees. (f) Well-demarcated erythematous rash in the napkin area involving the crural fold.
Table 6 Frequency, sensitivity and specificity of different numbers of




Cases, n (%) Controls, n (%)
N= 162 Sensitivity N= 146 Specificity
1 or more 154 (951) 951% 82 (562) 438%
2 or more 127 (784) 784% 42 (288) 712%
3 or more 104 (642) 642% 19 (130) 870%
4 or more 75 (463) 463% 6 (41) 959%
5 or more 47 (290) 290% 1 (07) 993%
6 or more 17 (105) 105% 0 0
7 5 (31) 31% 0 0
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diagnostic criteria. Future research should include validation
of the criteria in an external cohort. Complementary studies
could identify a shortlist of criteria using alternative tech-
niques such as decision making based on motivated choice or
latent class analysis.
The coefficient values from the prediction model can be
used as per the worked examples to calculate the probability
of a child developing psoriasis. However, the formula is
unlikely to be used in routine clinical practice, and further
scoping work is needed to establish whether there is appetite
for an accessible risk calculator. The sensitivity and specificity
of the predictive model are also not directly applicable to a
clinical or research population, because this is the diagnostic
accuracy of the model performance and not a specific number
of criteria. Therefore, to provide a more intuitive way for
using the criteria, external cutoffs in the number of criteria
were explored.
It is estimated that if any two of the seven criteria are pre-
sent, this will identify psoriasis in 78% of children with psori-
asis (sensitivity) and rule out psoriasis with 71% certainty in
children with other skin disorders (specificity). The acceptabil-
ity of these values for clinical practice will need to be
explored with clinicians. Depending on the setting and pur-
pose of using the diagnostic criteria, the number of criteria
required to support a diagnosis of psoriasis could be decreased
or increased, to improve sensitivity and specificity, respec-
tively. For example, for recruitment into clinical trials a higher
specificity would be desirable. Increasing the cutoff to any
four of the seven criteria increases the specificity to 96%.
In conclusion, this study provides history- and
examination-based data on the clinical features of psoriasis in
children and proposes seven diagnostic criteria with good dis-
criminatory ability in secondary-care patients. Three of the
best predictive criteria involve skin in hidden sites, such as
umbilicus, groin flexures and external auditory meatus. These
criteria will therefore be helpful to prompt examination of
these specific areas to determine whether a patient has psoria-
sis or not. The DIPSOC study was designed as a development
study and is a promising first step. Further studies are planned
to explore and validate the diagnostic performance of individ-
ual criteria and the collective seven best predictive criteria in
different datasets and settings.
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